To Invest or Not: Bionano Genomics (BNGO.Q)

In this episode, we look at a life sciences instrumentation company in the genome analysis space called Bionano Genomics (BNGO.Q). The company develops and markets the Saphyr system, a platform used for ultra-sensitive and ultra-specific structural variation detection. This Optical Genome Mapping (OGM) platform can detect these large Structural Variations responsible for genetic diseases and can reveal them at sensitivities as high as 99%, with false-positive rates below 2%. But how well has the Saphyr worked BNGO so far? We look at their tech, financial statements and stock price. Tune in!